A recent study showed that the synthetic lethal (negative epistasis) relationship between fumarate hydratase and haem oxygenase can be employed successfully to identify an in vitro drug target in hereditary leiomyomatosis and renal-cell cancer (HLRCC) cells [51]. This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.